Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Lombard Medical Inc. EVARF

Lombard Medical Inc is a medical technology company which specializes in developing, manufacturing, and marketing endovascular stent-grafts that address significant unmet needs in the repair of aortic aneurysms. The company's products include Aorfix which is an endovascular stent-graft with an approved indication that includes the repair of AAAs (Abdominal Aortic Aneurysms) in patients with aortic neck angulations from 0 to 90 degrees; IntelliFlex is delivery system for AAAs stent graft; Altura Endovascular Stent Graft System which is an ultra-low profile endovascular stent graft technology. The majority of the company's revenue is generated from Japan.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (EXPM:EVARF)

Fundamentals Snapshot (EXPM:EVARF)

Opinion & Analysis (EXPM:EVARF)

No current opinion is available.

Bullboard Posts (EXPM:EVARF)

There's nothing wrong with being 1st to post.

Just thought I'd buy a few. Sure is quite around here. Hopefully, that changes soon. Anyone else listen to the CC today? GLTA.
Ezzzra - May 7, 2020